Sleep disturbances as an adverse effect of propranolol use in children with infantile hemangioma  

作　　者：Ellen M.S.Xerfan Monica L.Andersen Anamaria S.Facina Sergio Tufik Jane Tomimori 

机构地区：[1]Programa de Pós-Gradua(c)(a)o em Medicina Translacional,Universidade Federal de S(a)o Paulo(UNIFESP),S(a)o Paulo,Brazil [2]Departamento de Dermatologia,Universidade Federal de S(a)o Paulo(UNIFESP),S(a)o Paulo,Brazil [3]Departamento de Psicobiologia,Universidade Federal de S(a)o Paulo(UNIFESP),S(a)o Paulo,Brazil

出　　处：《World Journal of Pediatrics》2020年第5期537-538,共2页世界儿科杂志（英文版）

摘　　要：Infantile hemangiomas(IHs)are the most prevalent benign vascular tumor in children,with an estimated rate of 5-10%.Most IHs resolve spontaneously after the proliferation stage,but about 12-24%develop with sequelae and complications which require pharmacological interventions[1].The beta blocker propranolol is considered as the first-line treatment for complicated cases of IHs[2].

关 键 词：PROPRANOLOL CHILDREN EFFECT 

分 类 号：R732.2[医药卫生—肿瘤]